基本資料
種類: ETF
費用比率%: 1.11
資產淨值: 20.46
成立日期: 23/04/1987
 
分析
市值分佈:
52.66%
大市值
23.01%
中市值
11.27%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 21/02/2026 06:08) 總持有投資項目: 92  
0%
 
100%
     10大 (23.91%)
代號 名稱 佔比% 持有日期
ALNYAlnylam Pharmaceuticals1.2731/01/2026
MRKMerck & Co1.2631/01/2026
EYPTEyePoint Inc.1.2431/01/2026
EWTXEdgewise Therapeutics1.2431/01/2026
ZTSZOETIS1.2331/01/2026
INSPInspire Medical Systems1.2331/01/2026
SPRYARS Pharmaceuticals1.2131/01/2026
ARWRArrowhead Pharmaceuticals1.2031/01/2026
ELVElevance Health1.1531/01/2026
SGEN1.0830/11/2023
JAZZJazz Pharmaceuticals plc1.0731/01/2026
MOHMolina Healthcare1.0431/01/2026
AXSMAxsome Therapeutics1.0231/01/2026
VRTXVertex Pharmaceuticals1.0031/01/2026
NAMSNewAmsterdam Pharma Company NV0.9931/01/2026
ADPTAdaptive Biotechnologies Corp0.9831/01/2026
MDTMedtronic plc0.9431/01/2026
TVTXTravere Therapeutics0.9431/01/2026
PODDInsulet Corp0.9331/01/2026
IDYAIDEAYA Biosciences0.9231/01/2026
  1   2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.